Skip to main content

Science
Products
Stories
Newsroom
About

Investors Media Careers Partners

Careers
Investors

Changed

Changed

How can we help you?

0 search results for

Suggestions within Pfizer.com

Home
News
Press Releases

Press Release Archive

Press Releases

Year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Month

January

February

March

April

May

June

July

August

September

October

November

December

View 12

View 24

View 48

Categories

Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines

Keywords

All Keywords

Covid-19
Finance
Investments
Leadership
Medicines
Partnerships
Research
Responsibility
Vaccines

June 2013

06.24.2013
Pfizer Invites Public To View And Listen To Webcast Of July 30 Conference Call With Analysts
06.23.2013
Pfizer Announces Preliminary Results of Zoetis Exchange Offer and Adjusts 2013 Financial Guidance(1) Solely to Reflect Impact of Exchange Offer
06.20.2013
Pfizer Announces FDA Acceptance For Review Of Application To Expand Labeling For XELJANZ® (tofacitinib citrate) For Adults With Moderately To Severely Active Rheumatoid Arthritis To Include Inhibition Of Progression Of Structural Damage
06.19.2013
Pfizer Announces Final Exchange Ratio Of 0.9898 For Zoetis Exchange Offer And Automatic Extension Of Offer To Midnight On Friday, June 21, 2013
06.11.2013
Pfizer Obtains $2.15 Billion Settlement From Teva And Sun For Infringement Of Protonix® Patent
06.06.2013
CytomX Announces Global Strategic Collaboration with Pfizer to Develop and Commercialize Multiple Probody™-Drug Conjugates in Oncology
- Partnerships
06.04.2013
Americans Believe Their Communities Are Ill-Prepared For Aging Population, New Survey Reveals; Survey Shows A Fear Of Getting Old Due To Health And Financial Concerns

May 2013

05.28.2013
Pfizer Prices $4.0 Billion Debt Offering
05.21.2013
Pfizer Announces Plan for Split-Off of Zoetis
05.20.2013
Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility
05.12.2013
Pfizer Announces 11 Abstracts for Tofacitinib to Be Presented at the European League Against Rheumatism (EULAR) 2013 Annual Meeting
05.08.2013
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

Page 142
Page 143
Current page 144
Page 145
Page 146

Media Resources & Contact Information

Media Contacts
Press Kits

Anyone may view our press releases, press statements, and press kits.

However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.

Investors
Media
Careers
Partners

PfizerForAll
Healthcare Professionals
Grant Seekers
Business to Business

Privacy Statement
Accessibility Statement
Terms of Use
Contact Us

Glossary

© 2025 Pfizer Inc. All rights reserved

This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.

Twitter
Facebook
Linked In
Instagram
Youtube